Characteristic clinical features associated with aggressive posterior retinopathy of prematurity
Sign Up to like & getrecommendations! Published in 2017 at "Eye"
DOI: 10.1038/eye.2017.18
Abstract: PurposeTo identify the risk factors for, and clinical features and treatment outcomes of aggressive posterior retinopathy of prematurity (APROP) in Korean infants.MethodsAmong 770 premature infants who underwent screening, 105 infants (198 eyes, 13.63%) received treatment… read more here.
Keywords: clinical features; aggressive posterior; posterior retinopathy; treatment ... See more keywords
Aggressive posterior retinopathy of prematurity: a review on current understanding
Sign Up to like & getrecommendations! Published in 2021 at "Eye"
DOI: 10.1038/s41433-021-01392-6
Abstract: A review of literature was performed, focused on the etiopathogenesis of aggressive posterior retinopathy of prematurity (APROP), the characteristic and atypical clinical features, management strategies, anatomical and visual outcomes. Characteristically APROP has zone I/posterior zone… read more here.
Keywords: aggressive posterior; posterior retinopathy; aprop; review ... See more keywords
RETINAL VASCULAR DEVELOPMENT WITH 0.312 MG INTRAVITREAL BEVACIZUMAB TO TREAT SEVERE POSTERIOR RETINOPATHY OF PREMATURITY: A Longitudinal Fluorescein Angiographic Study
Sign Up to like & getrecommendations! Published in 2017 at "Retina"
DOI: 10.1097/iae.0000000000001126
Abstract: Purpose: To report the outcome of intravitreal 0.312 mg bevacizumab (IVB) monotherapy in acute retinopathy of prematurity (ROP) and to describe the vascular development over time. Methods: Seventeen prematurely born infants were treated with IVB… read more here.
Keywords: bevacizumab; aggressive posterior; rop; vascular development ... See more keywords
Outcomes of Nonconfluent Diode Laser Panretinal Photocoagulation for Aggressive Posterior Retinopathy of Prematurity After Intravitreal Bevacizumab.
Sign Up to like & getrecommendations! Published in 2020 at "Retina"
DOI: 10.1097/iae.0000000000002943
Abstract: PURPOSE To assess the safety and efficacy of less dense pan-retinal photocoagulation (PRP) after intravitreal bevacizumab in aggressive posterior retinopathy of prematurity (APROP) infants. METHODS Retrospective consecutive case series of premature infants diagnosed with APROP… read more here.
Keywords: intravitreal bevacizumab; bevacizumab; diode laser; posterior retinopathy ... See more keywords
Role of complete laser photocoagulation and wide-field imaging in aggressive posterior retinopathy of prematurity
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-230031
Abstract: A premature baby born at 28 weeks of gestation, post menstrual age (PMA) of 35 weeks, and birth weight of 1000 g presented to us with the diagnosis of aggressive posterior retinopathy of prematurity (APROP). The… read more here.
Keywords: laser photocoagulation; aggressive posterior; posterior retinopathy; retinopathy prematurity ... See more keywords
Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.778585
Abstract: Purpose The purpose of this study is to review the neonatal and early childhood course of children who were treated with intravitreal bevacizumab for APROP and identify any long term limitations these children face years… read more here.
Keywords: posterior retinopathy; prematurity; long term; intravitreal bevacizumab ... See more keywords
Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
Sign Up to like & getrecommendations! Published in 2021 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_373_21
Abstract: Published in this issue of Indian Journal of Ophthalmology is a retrospective cohort of 24 infants with posterior zone 1 or ‘zone half’ aggressive posterior retinopathy of prematurity (APROP) who underwent intravitreal ranibizumab followed by… read more here.
Keywords: vascular endothelial; posterior zone; ophthalmology; retinopathy prematurity ... See more keywords
Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
Sign Up to like & getrecommendations! Published in 2019 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_884_17
Abstract: A preterm infant with zone 1 aggressive posterior retinopathy of prematurity developed infectious endophthalmitis after intravitreal injection of ranibizumab. Urgent empirical intravitreal therapy with vancomycin, ceftazidime, and dexamethasone along with intravenous therapy with amikacin and… read more here.
Keywords: aggressive posterior; posterior retinopathy; retinopathy prematurity; injection ... See more keywords
Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
Sign Up to like & getrecommendations! Published in 2019 at "Taiwan Journal of Ophthalmology"
DOI: 10.4103/tjo.tjo_139_18
Abstract: However, a few points need to be answered. The authors did not categorize the outcomes with respect to zones of involvement. Although classically APROP is seen in Zone I, it can be seen in posterior… read more here.
Keywords: laser aggressive; laser; aggressive posterior; bevacizumab laser ... See more keywords